- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
GU Cancers Symposium 2011: ASCO ASTRO SUO - Initial report of RTOG 9601, a phase III trial in prostate cancer - Session Highlights
February 24, 2011
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer - Abstract
February 23, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer - Abstract
February 23, 2011
Testicular metastases from prostate cancer - Abstract
February 23, 2011
Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract
February 22, 2011
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract
February 22, 2011
The effects of body mass index on changes in prostate specific antigen levels and prostate volume: Implications for prostate cancer detection - Abstract
February 22, 2011
Prostate cancer screening and informed decision-making: Provider and patient perspectives - Abstract
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of translational aspects of drug development in prostate cancer - Session Highlights
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Immune targeting in prostate cancer - Session Highlights
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Aspects of the androgen receptor pathway in prostate cancer - Session Highlights
February 22, 2011
A case of robot-assisted laparoscopic radical prostatectomy in primary small cell prostate cancer - Abstract
February 21, 2011
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: Late toxicity - Abstract
February 21, 2011